Radiation InjuriesRadiation DosageRadiation, IonizingDose-Response Relationship, RadiationRadiotherapyRadiotherapy DosageCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsRadiation ToleranceRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiationAntineoplastic AgentsRadiation OncologyRadiation ProtectionDose FractionationRadiotherapy, AdjuvantChemotherapy, AdjuvantRadiation MonitoringRadiotherapy Planning, Computer-AssistedTreatment OutcomeBrachytherapyRadiation PneumonitisCisplatinNeoplasmsRadiosurgeryRadiometryNeoplasm Recurrence, LocalRadiation-Sensitizing AgentsNeoplasms, Radiation-InducedDoxorubicinNeoplasm StagingBrain NeoplasmsCranial IrradiationRadiation Injuries, ExperimentalRadiotherapy, Computer-AssistedBreast NeoplasmsDisease-Free SurvivalGamma RaysSurvival AnalysisHead and Neck NeoplasmsRadiotherapy, Image-GuidedParticle AcceleratorsCell Line, TumorSurvival RateCosmic RadiationRadiotherapy, High-EnergyRadiodermatitisLung NeoplasmsPrognosisTime FactorsRadiation-Protective AgentsOrgans at RiskCarcinoma, Squamous CellChemoradiotherapyFollow-Up StudiesProstatic NeoplasmsAdenocarcinomaEtoposideCyclophosphamideBackground RadiationRetrospective StudiesTomography, X-Ray ComputedNeoadjuvant TherapyDrug Screening Assays, AntitumorApoptosisCobalt RadioisotopesMastectomy, SegmentalPaclitaxelDrug Resistance, NeoplasmCell SurvivalUltraviolet RaysTumor BurdenDacarbazineActuarial AnalysisAntineoplastic Agents, PhytogenicHodgkin DiseaseCarcinoma, Non-Small-Cell LungDrug Administration ScheduleRadiation EffectsVinblastineRadiobiologyDNA DamageBleomycinCarboplatinGlioblastomaLymphatic IrradiationAntineoplastic Agents, AlkylatingFluorouracilSarcomaX-RaysRectal NeoplasmsClinical Trials as TopicAntibiotics, AntineoplasticNeoplasms, Second PrimaryMice, NudeAntimetabolites, AntineoplasticFour-Dimensional Computed TomographyXenograft Model Antitumor AssaysNeoplasm Metastasis